Educational Series – Malignant pleural mesothelioma: recent developments

We are delighted to add our latest Educational Series titled: Malignant pleural mesothelioma; recent developments in its treatment landscape. This review summarises developments in the treatment landscape in Australia, highlighting outcomes from a study of nivolumab and ipilimumab compared with chemotherapy in patients with unresectable disease.

The review includes guiding commentary from Dr Anthony Linton, a medical oncologist at the Concord Cancer Centre in Concord Repatriation General Hospital.

 

Please login below to download this issue (PDF)

Subscribe